Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Harbour BioMed Advances Global Strategic Collaboration with AstraZeneca to Discover and Develop Next-Generation Biotherapeutics in Oncology 2025-11-24 08:01
Harbour BioMed and Evinova China Announce Strategic AI Collaboration to Accelerate AI-Enabled Drug Development 2025-11-07 14:00
Harbour BioMed Launches First Fully Human Generative AI HCAb Model to Accelerate Next-Generation Biologics Discovery 2025-10-28 22:07
Harbour BioMed Reports 2025 Interim Results 2025-08-27 22:40
Harbour BioMed Appoints Yajie Li as Chief Medical Officer 2025-08-25 09:00
Harbour BioMed to Present Phase II Data of HBM4003 and Tislelizumab Combination in MSS Metastatic Colorectal Cancer at ESMO 2025 2025-07-30 08:01
Harbour BioMed Announces Positive Profit Alert for 2025 Interim Results 2025-07-28 08:11
HBM9378/WIN378, a Long-Acting, Fully Human Anti-TSLP Antibody, Enters Global Phase 2 POLARIS Trial for Asthma 2025-07-23 20:36
Harbour BioMed Enters Global Strategic Collaboration with Otsuka to Advance BCMAxCD3 Bispecific T-Cell Engagers 2025-06-23 08:03
China National Intellectual Property Administration Affirms Validity of Harbour BioMed's Patent; Infringement Lawsuit Moves Forward 2025-06-16 20:33
Harbour BioMed Appoints Youchen Chen as Chief Financial Officer 2025-04-10 10:00
Harbour BioMed Reports Full Year 2024 Financial Results 2025-03-31 18:13
Harbour BioMed Enters into Global Strategic Collaboration with AstraZeneca to Discover and Develop Next-Generation Therapeutic Antibodies 2025-03-21 19:21
Harbour BioMed Launches Élancé Therapeutics to Advance Next-Generation Obesity Therapies 2025-03-12 12:41
Harbour BioMed Appoints Dr. Ian Y. Liu as Global Head of Legal 2025-03-11 08:00
Harbour BioMed Appoints Michael D. Patten as Chief Strategy Officer 2025-03-11 08:00
HBM Alpha Therapeutics Enters Strategic Collaboration and License Agreement to Advance Novel Endocrine Therapies 2025-02-26 08:03
Harbour BioMed and Insilico Medicine Achieve Strategic Collaboration to Advance AI-Driven Antibody Discovery and Development 2025-02-20 15:31
Harbour BioMed Announces Business Progress and Update 2025-02-14 12:08
Harbour BioMed Receives NMPA IND Clearance for HBM9378/SKB378 in the Treatment of Chronic Obstructive Pulmonary Disease 2025-02-05 12:28